IS4949A - Setnar tríazóló-pýridazín afleiður sem bindlar fyrir GABA viðtaka - Google Patents

Setnar tríazóló-pýridazín afleiður sem bindlar fyrir GABA viðtaka

Info

Publication number: IS4949A
Authority: IS; Iceland
Prior art keywords: triazolo; establishes; bind; pyridazine derivatives; gaba receptors
Prior art date: 1996-07-25

Application number

IS4949A

Other languages

English (en)

Inventor

Barff Broughton Howard

Richard Guiblin Alexander

Geoffrey Russell Michael

Robert Carling William

Madin Andrew

Joseph Street Leslie

Luis Castro Pineiro Jose

William Moore Kevin

Original Assignee

Merck Sharp & Dohme Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-25

Filing date

1999-01-19

Publication date

1999-01-19

1996-07-25 Priority claimed from GBGB9615645.0A external-priority patent/GB9615645D0/en

1996-12-06 Priority claimed from GBGB9625397.6A external-priority patent/GB9625397D0/en

1997-07-09 Priority claimed from GBGB9714420.8A external-priority patent/GB9714420D0/en

1999-01-19 Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited

1999-01-19 Publication of IS4949A publication Critical patent/IS4949A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IS4949A 1996-07-25 1999-01-19 Setnar tríazóló-pýridazín afleiður sem bindlar fyrir GABA viðtaka IS4949A (is)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9615645.0A GB9615645D0 (en)	1996-07-25	1996-07-25	Therapeutic agents
GBGB9625397.6A GB9625397D0 (en)	1996-12-06	1996-12-06	Therapeutic agents
GBGB9714420.8A GB9714420D0 (en)	1997-07-09	1997-07-09	Therapeutic agents
PCT/GB1997/001946 WO1998004559A2 (en)	1996-07-25	1997-07-17	Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (1)

Publication Number	Publication Date
IS4949A true IS4949A (is)	1999-01-19

Family

ID=27268403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4949A IS4949A (is)	1996-07-25	1999-01-19	Setnar tríazóló-pýridazín afleiður sem bindlar fyrir GABA viðtaka

Country Status (24)

Country	Link
US (1)	US6255305B1 (is)
EP (1)	EP0915875B1 (is)
JP (1)	JP4216905B2 (is)
KR (1)	KR20000029548A (is)
CN (1)	CN1251589A (is)
AT (1)	ATE236904T1 (is)
AU (1)	AU723098B2 (is)
BG (1)	BG103112A (is)
BR (1)	BR9710729A (is)
CZ (1)	CZ18199A3 (is)
DE (1)	DE69720732T2 (is)
EA (1)	EA002436B1 (is)
EE (1)	EE9900027A (is)
ES (1)	ES2194205T3 (is)
HU (1)	HUP0600527A2 (is)
IL (1)	IL127911A0 (is)
IS (1)	IS4949A (is)
NO (1)	NO990304L (is)
NZ (1)	NZ333768A (is)
PL (1)	PL331072A1 (is)
SK (1)	SK9399A3 (is)
TR (1)	TR199900047T2 (is)
WO (1)	WO1998004559A2 (is)
YU (1)	YU2899A (is)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4672820B2 (ja) *	1997-05-08	2011-04-20	メルクシャープエンドドームリミテッド	ＧＡＢＡα５リガンドとしての置換１，２，４−トリアゾロ［３，４−ａ］フタラジン誘導体
GB9715977D0 (en) *	1997-07-29	1997-10-01	Merck Sharp & Dohme	Therapeutic agents
US6297235B1 (en)	1997-08-28	2001-10-02	Merck Sharp & Dohme Ltd.	Triazolopyridazine derivatives for treating anxiety and enhancing cognition
GB9718254D0 (en)	1997-08-28	1997-11-05	Merck Sharp & Dohme	Therapeutic agents
GB9723999D0 (en)	1997-11-13	1998-01-14	Merck Sharp & Dohme	Therapeutic use
GB9726701D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
GB9726699D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
GB9726702D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
AU1041599A (en) *	1997-11-13	1999-06-07	Jose Luis Castro Pineiro	Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) *	1997-12-18	2000-08-29	Merck & Co., Inc.	Antiemetic use of triazolo-pyridazine derivatives
JP2002509150A (ja) *	1998-01-14	2002-03-26	メルクシャープエンドドームリミテッド	Ｇａｂａ受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9801234D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801202D0 (en)	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
SK10922000A3 (sk) *	1998-01-21	2001-03-12	Merck Sharp & Dohme Limited	Triazolopyridazínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
GB9801210D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801208D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801397D0 (en) *	1998-01-22	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801538D0 (en) *	1998-01-23	1998-03-25	Merck Sharp & Dohme	Pharmaceutical product
GB9813006D0 (en) *	1998-06-16	1998-08-12	Merck Sharp & Dohme	Therapeutic agents
CA2334836A1 (en)	1998-06-16	1999-12-23	Merck Sharp & Dohme Limited	Triazolo-pyridine derivatives as ligands for gaba receptors
GB9813576D0 (en) *	1998-06-24	1998-08-19	Merck Sharp & Dohme	Therapeutic agents
GB9821179D0 (en) *	1998-09-30	1998-11-25	Merck Sharp & Dohme	Therapeutic use
EP1120418A4 (en) *	1998-10-06	2005-01-26		CONDENSED PYRIDAZINE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF
AU760688B2 (en) *	1998-10-16	2003-05-22	Merck Sharp & Dohme Limited	Pyrazolo-triazine derivatives as ligands for GABA receptors
IT1303272B1 (it)	1998-10-29	2000-11-06	Zambon Spa	Derivati triciclici inibitori della fosfodiesterasi 4
GB9824897D0 (en) *	1998-11-12	1999-01-06	Merck Sharp & Dohme	Therapeutic compounds
GB2345443A (en) *	1999-01-08	2000-07-12	Merck Sharp & Dohme	Use of triazolo-pyridazines for treating premenstrual syndrome
EP1149102B1 (en) *	1999-01-27	2004-12-08	MERCK SHARP & DOHME LTD.	Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9903119D0 (en) *	1999-02-11	1999-04-07	Merck Sharp & Dohme	Therapeutic agents
US6737242B1 (en)	1999-05-07	2004-05-18	Neurogen Corporation	Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9919957D0 (en)	1999-08-23	1999-10-27	Merck Sharp & Dohme	Therapeutic agents
GB9921351D0 (en) *	1999-09-09	1999-11-10	Merck Sharp & Dohme	Therapeutic agents
US6355638B1 (en) *	1999-11-25	2002-03-12	Merck Sharp & Dohme Ltd.	Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
GB9929569D0 (en) *	1999-12-14	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB9929687D0 (en) *	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB9929685D0 (en) *	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB0000564D0 (en) *	2000-01-11	2000-03-01	Merck Sharp & Dohme	Therapeutic agents
GB0008696D0 (en)	2000-04-07	2000-05-31	Merck Sharp & Dohme	Therapeutic agents
GB0017518D0 (en) *	2000-07-17	2000-08-30	Merck Sharp & Dohme	Therapeutic agents
GB0018473D0 (en) *	2000-07-27	2000-09-13	Merck Sharp & Dohme	Therapeutic agents
GB0028583D0 (en)	2000-11-23	2001-01-10	Merck Sharp & Dohme	Therapeutic compounds
GB0108475D0 (en) *	2001-04-04	2001-05-23	Merck Sharp & Dohme	New compounds
US6960584B2 (en) *	2001-04-10	2005-11-01	Merck & Co., Inc.	Inhibitors of Akt activity
WO2002083140A1 (en)	2001-04-10	2002-10-24	Merck & Co., Inc.	Inhibitors of akt activity
WO2002083139A1 (en)	2001-04-10	2002-10-24	Merck & Co., Inc.	Inhibitors of akt activity
EP1379250A2 (en) *	2001-04-10	2004-01-14	Merck & Co., Inc.	A method of treating cancer
GB0122696D0 (en) *	2001-09-20	2001-11-14	Merck Sharp & Dohme	Therapeutic agents
GB0128499D0 (en) *	2001-11-28	2002-01-23	Merck Sharp & Dohme	Therapeutic agents
US20060142178A1 (en) *	2002-04-08	2006-06-29	Barnett Stanley F	Method of treating cancer
GB0218876D0 (en) *	2002-08-13	2002-09-25	Merck Sharp & Dohme	Therapeutic agents
DE60325865D1 (de) *	2002-08-13	2009-03-05	Merck Sharp & Dohme	Phenylpyridazin derivative als liganden für gaba-rezeptoren
KR101075812B1 (ko) *	2002-12-18	2011-10-25	버텍스 파마슈티칼스 인코포레이티드	단백질 키나제 억제제로서의 트리아졸로피리다진
AU2004309368A1 (en)	2003-12-19	2005-07-14	Bristol-Myers Squibb Company	Azabicyclic heterocycles as cannabinoid receptor modulators
CN101133057B (zh) *	2004-09-02	2011-03-09	尼科梅德有限责任公司	三唑并酞嗪化合物
WO2006061428A2 (en) *	2004-12-10	2006-06-15	Universität Zürich	Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
CA2591991C (en)	2005-01-05	2013-11-19	Altana Pharma Ag	Triazolophthalazines
JP5240899B2 (ja)	2005-01-05	2013-07-17	タケダゲゼルシャフトミットベシュレンクテルハフツング	トリアゾロフタラジン
US7572807B2 (en)	2005-06-09	2009-08-11	Bristol-Myers Squibb Company	Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
EP2258358A3 (en)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
JP2009513672A (ja) *	2005-10-31	2009-04-02	ブレインセルス，インコーポレイティド	神経発生のｇａｂａ受容体媒介調節
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
WO2007134077A2 (en)	2006-05-09	2007-11-22	Braincells, Inc.	5 ht receptor mediated neurogenesis
MX2009002496A (es)	2006-09-08	2009-07-10	Braincells Inc	Combinaciones que contienen un derivado de 4-acilaminopiridina.
US7638541B2 (en)	2006-12-28	2009-12-29	Metabolex Inc.	5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
WO2009014910A2 (en)	2007-07-19	2009-01-29	Metabolex, Inc.	N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
US8809355B2 (en)	2008-04-04	2014-08-19	Innovationspatent Sverige Ab	GABAA receptor modulators
PL2328414T3 (pl) *	2008-08-29	2014-05-30	Concert Pharmaceuticals Inc	Podstawione pochodne triazolo-pirydazyny
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
EP2454259A1 (en)	2009-06-23	2012-05-23	Concert Pharmaceuticals Inc.	Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
WO2011041154A1 (en)	2009-10-01	2011-04-07	Metabolex, Inc.	Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
US8278460B2 (en)	2009-10-15	2012-10-02	Concert Pharmaceuticals, Inc.	Substituted benzimidazoles
PH12012501361A1 (en)	2009-12-31	2012-10-22	Centro Nac De Investigaciones Oncologicas Cnio	Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en)	2011-01-18	2012-07-26	Centro Nacional De Investigaciones Oncológicas (Cnio)	6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005041A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	Tricyclic heterocyclic compounds as kinase inhibitors
WO2013005057A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	New compounds
WO2013004984A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncologicas (Cnio)	Tricyclic compounds for use as kinase inhibitors
MX2015005375A (es) *	2012-11-07	2015-07-21	Hoffmann La Roche	Compuestos de triazolo.
KR102482200B1 (ko)	2016-01-27	2022-12-27	우니페르지타에트 취리히	가려움증 치료를 위한 ｇａｂａａ 수용체 조절인자의 용도
CN107344936B (zh) *	2016-05-06	2022-06-03	上海赛默罗生物科技有限公司	三唑哒嗪类衍生物、其制备方法、药物组合物和用途
CN107344938B (zh) *	2016-05-06	2022-05-06	上海赛默罗生物科技有限公司	吡唑-三嗪类衍生物、其制备方法、药物组合物和用途
WO2018026890A1 (en)	2016-08-03	2018-02-08	Cymabay Therapeutics	Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
EP3796907A4 (en)	2018-05-22	2021-11-03	Neurocycle Therapeutics, Inc.	GABAA POSITIVE ALLOSTERIC MODULATING COMPOUNDS FOR THE TREATMENT OF PRURITUS AND / OR DERMATITIS
EP4048266A4 (en) *	2019-10-23	2024-07-10	Neurocycle Therapeutics, Inc.	TREATMENT OF EPILEPTIC CONDITIONS WITH GABAa RECEPTOR MODULATORS
WO2023150377A1 (en) *	2022-02-07	2023-08-10	The Regents Of The University Of Colorado, A Body Corporate	Small molecule cxcr4 agonists, method of synthesis, and method of use
CN120172922A (zh) *	2022-04-15	2025-06-20	内蒙古京科医药科技有限公司	一种1-甲基-1,2,4-三氮唑-3-甲醇及其制备方法
CN114591352B (zh) *	2022-05-11	2022-09-09	上海赛默罗生物科技有限公司	一种三唑并哒嗪类化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1080712A (en) *	1976-09-22	1980-07-01	Jay D. Albright	Hypotensive agents
PH21834A (en)	1982-01-18	1988-03-17	Lepetit Spa	New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
US4487930A (en)	1982-09-07	1984-12-11	The Dow Chemical Company	6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
IT1194310B (it) *	1983-07-12	1988-09-14	Lepetit Spa	Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4578464A (en)	1983-11-22	1986-03-25	Merrell Dow Pharmaceuticals Inc.	6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine and related compounds
FR2562071B1 (fr) *	1984-03-30	1986-12-19	Sanofi Sa	Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
GB9321162D0 (en)	1993-10-13	1993-12-01	Boots Co Plc	Therapeutic agents
GB9507348D0 (en) *	1995-04-08	1995-05-31	Knoll Ag	Therapeutic agents
GB9726702D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use

1997
- 1997-07-17 BR BR9710729A patent/BR9710729A/pt unknown
- 1997-07-17 AT AT97931960T patent/ATE236904T1/de not_active IP Right Cessation
- 1997-07-17 NZ NZ333768A patent/NZ333768A/xx unknown
- 1997-07-17 TR TR1999/00047T patent/TR199900047T2/xx unknown
- 1997-07-17 CN CN97196641A patent/CN1251589A/zh active Pending
- 1997-07-17 US US09/155,587 patent/US6255305B1/en not_active Expired - Lifetime
- 1997-07-17 DE DE69720732T patent/DE69720732T2/de not_active Expired - Lifetime
- 1997-07-17 HU HU0600527A patent/HUP0600527A2/hu unknown
- 1997-07-17 CZ CZ99181A patent/CZ18199A3/cs unknown
- 1997-07-17 SK SK93-99A patent/SK9399A3/sk unknown
- 1997-07-17 EP EP97931960A patent/EP0915875B1/en not_active Expired - Lifetime
- 1997-07-17 ES ES97931960T patent/ES2194205T3/es not_active Expired - Lifetime
- 1997-07-17 WO PCT/GB1997/001946 patent/WO1998004559A2/en not_active Ceased
- 1997-07-17 YU YU2899A patent/YU2899A/sh unknown
- 1997-07-17 JP JP50858598A patent/JP4216905B2/ja not_active Expired - Fee Related
- 1997-07-17 EA EA199900164A patent/EA002436B1/ru not_active IP Right Cessation
- 1997-07-17 IL IL12791197A patent/IL127911A0/xx unknown
- 1997-07-17 EE EEP199900027A patent/EE9900027A/xx unknown
- 1997-07-17 KR KR1019997000606A patent/KR20000029548A/ko not_active Withdrawn
- 1997-07-17 PL PL97331072A patent/PL331072A1/xx unknown
- 1997-07-17 AU AU35539/97A patent/AU723098B2/en not_active Ceased
1999
- 1999-01-19 IS IS4949A patent/IS4949A/is unknown
- 1999-01-22 NO NO990304A patent/NO990304L/no not_active Application Discontinuation
- 1999-01-25 BG BG103112A patent/BG103112A/xx unknown

Also Published As

Publication number	Publication date
EA002436B1 (ru)	2002-04-25
HUP0600527A2 (en)	2006-11-28
JP4216905B2 (ja)	2009-01-28
PL331072A1 (en)	1999-06-21
ES2194205T3 (es)	2003-11-16
EA199900164A1 (ru)	2000-04-24
EP0915875B1 (en)	2003-04-09
CN1251589A (zh)	2000-04-26
NZ333768A (en)	2000-09-29
NO990304D0 (no)	1999-01-22
AU3553997A (en)	1998-02-20
BR9710729A (pt)	1999-08-17
DE69720732D1 (de)	2003-05-15
US6255305B1 (en)	2001-07-03
TR199900047T2 (xx)	1999-03-22
SK9399A3 (en)	2000-04-10
KR20000029548A (ko)	2000-05-25
WO1998004559A2 (en)	1998-02-05
JP2002514169A (ja)	2002-05-14
CZ18199A3 (cs)	1999-06-16
YU2899A (sh)	2000-03-21
EE9900027A (et)	1999-08-16
ATE236904T1 (de)	2003-04-15
NO990304L (no)	1999-03-25
BG103112A (en)	1999-09-30
EP0915875A2 (en)	1999-05-19
AU723098B2 (en)	2000-08-17
IL127911A0 (en)	1999-11-30
DE69720732T2 (de)	2004-01-29

Publication	Publication Date	Title
IS4949A (is)	1999-01-19	Setnar tríazóló-pýridazín afleiður sem bindlar fyrir GABA viðtaka
ATE202361T1 (de)	2001-07-15	N6-heterocyclisch-substituierte adenosin-derivate
ATE180776T1 (de)	1999-06-15	Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
DK0920429T3 (da)	2003-05-12	Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
IS4963A (is)	1999-01-29	Setnar 6,5-heteró-bísýklískar afleiður
ID18505A (id)	1998-04-16	Proses produksi seluri batu bara-air, sistim untuk itu, dan alat pemindah seluri
NO20000935L (no)	2000-04-18	Fremgangsmåte for inhibering av komplementaktivering via den alternative reaksjonsvei
MA26504A1 (fr)	2004-12-20	Derives benzimidazole.
NO976110D0 (no)	1997-12-29	Nettverk med server, spesielt for oppsetting av anrop
NO975293D0 (no)	1997-11-18	Fremgangsmåte for mottaking, samt mottaker
DK0922050T3 (da)	2003-11-24	3-Descladinose-2,3-anhydroerythromycin-derivater
DE19781618T1 (de)	1999-04-15	Verbrennungssystem für Einrichtungen, die rußigen Rauch erzeugen
EP1007553A4 (en)	2004-09-22	ZONULA OCCLUDENS TOXIN RECEPTORS
NO976109D0 (no)	1997-12-29	Nettverk med server, spesielt for oppsetting av anrop
DE69628458D1 (de)	2003-07-03	25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
DE59508403D1 (de)	2000-06-29	14alpha,17alpha-c2-überbrückte 19-nor-progesteronderivate
TR199801492A3 (tr)	1999-02-22	Sülfonamid-ikame etmis bilesikleri elde etme usulleri.
TR199700219A3 (tr)	1997-10-21	1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
EP1012233A4 (en)	2004-05-06	TRANSGEN PRODUCED PROLACTIN
FI97609C (fi)	1997-01-27	Menetelmä partikkelien, erityisesti lastujen, kuivaamiseksi
FI980701A0 (fi)	1998-03-27	Foerfarande foer kontrollering av den tid som en process tar
NO961629D0 (no)	1996-04-24	Metode for etablering av dimensjonsvariable kjededannende, korsbindende trekonstruksjoner
ES1031926Y (es)	1996-08-01	Luminaria empotrada, perfeccionada.
NL1010152A1 (nl)	2000-03-24	Decoratieve lamphouderstructuur voor de kerst.
NL1003999C1 (nl)	1996-10-23	Ophangsysteem voor gordijnen.